Jefferies Downgrades Medpace Holdings to Hold, Raises Price Target to $515

Benzinga · 07/07 09:48
Jefferies analyst David Windley downgrades Medpace Holdings (NASDAQ:MEDP) from Buy to Hold and raises the price target from $490 to $515.